# ISIS Biopolymer

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/isis-biopolymer

- Industry: Biotechnology
- Headquarters: Providence, US
- Website: https://isisbiopolymer.com
- Total disclosed funding: $3M
- Latest round: Series C (Mar 3, 2010)
- Investors on record: 1

## About

ISIS Biopolymer, Inc. specializes in developing innovative biopolymer solutions, focusing on sustainable materials and advanced manufacturing techniques to enhance environmental performance across various industries.Founded in 2006 and headquartered in Providence, US, ISIS Biopolymer, Inc. creates biopolymer products aimed at reducing environmental impact. The company does not have any known subsidiaries or parent companies. Prior to its establishment, the founder might have had experience in related fields, though specific details are not provided. The company received its latest funding of USD 3 million in Series C financing in March 2010 from Castile Ventures, bringing the total amount raised to USD 3 million with a current valuation of USD 28.326 mn.ISIS Biopolymer, Inc. offers a range of biopolymer solutions that cater to multiple sectors, focusing on environmentally friendly materials. Their product lineup includes advanced biopolymers designed for various applications, such as packaging and consumer goods, aimed at enhancing sustainability and efficiency. They serve a diverse clientele from small businesses to large corporations, with a presence in North America, Europe, and Asia-Pacific.The company generates revenue through the sale of its biopolymer products, with clients engaging in contracts that ensure ongoing revenue streams. The pricing structure is tailored to meet client needs, and partnerships with retailers enhance market reach. Revenue is supported by a transactional framework that facilitates business interactions, promoting growth.Moving forward, ISIS Biopolymer, Inc. plans to introduce new biopolymer products designed for specific industry applications by 2022. The company aims to expand into international markets, specifically targeting regions in Europe and Asia-Pacific by 2023. The recent Series C funding of USD 3 million will be utilized to support product development and market expansion initiatives.

## Funding rounds

- Series C, Mar 3, 2010, $3M — Castile Ventures

## Investors

- Castile Ventures (https://capitalatlas.ai/funds/castile-ventures) — Series C